RLAY
Relay Therapeutics, Inc.
$16.51+0.04 (+0.24%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Jul 16, 2020 – Nov 18, 2026, Dividends reinvested
- Final balance
- $4,710
- CAGR
- −11.19%
- Max drawdown
- −96.75%
Trailing returns (%)
RLAY's average annual return was −13.97% over the last 5 years, through Nov 18, 2026. $10,000 in RLAY on Nov 18, 2021 fell to $4,712 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +1.41%
- 3M
- −19.89%
- 6M
- +36.45%
- YTD
- +95.15%
- 1Y
- +153.61%
Per year
- 3Y
- +24.19%
- 5Y
- −13.97%
- Since 2020
- −11.19%
Annual returns
2020 from Jul 16 · 2026 through Nov 18
RLAY returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +95.15% |
| 2025 | +105.34% |
| 2024 | −62.58% |
| 2023 | −26.31% |
| 2022 | −51.35% |
| 2021 | −26.11% |
| 2020 from Jul 16 | +18.57% |
Metrics
Since 2020| Volatility | 76.46% |
|---|---|
| Sharpe ratio | 0.22 |
| Sortino ratio | 0.34 |
| Calmar ratio | −0.12 |
| Longest drawdown | 5.8 years |
Worst drawdowns
Since 2020| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −96.7% | Jan 2021 | Apr 2025 | Not yet | 5.8 years so far |
| −31.0% | Nov 2020 | Jan 2021 | Jan 2021 | 2 months |
| −25.4% | Jul 2020 | Aug 2020 | Sep 2020 | 2 months |
| −21.4% | Oct 2020 | Nov 2020 | Nov 2020 | 1 month |
| −15.7% | Sep 2020 | Sep 2020 | Oct 2020 | 2 weeks |